Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.80 | €3.00 | 66.343% |
| Evotec SE | 4 | 1 | 1 | 0 | €9.47 | €21.50 | 127.033% |
| Elanco Animal Health Inc. | 6 | 3 | 0 | 0 | €12.43 | €15.50 | 24.690% |
| Grifols S.A. ADR | 0 | 1 | 0 | 0 | €5.80 | - | - |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.83 | €5.51 | 562.813% |
| Carl Zeiss Meditec AG | 2 | 1 | 1 | 0 | €100.30 | €101.00 | 0.698% |
| Neogen Corp. | 1 | 1 | 0 | 0 | €11.30 | €20.08 | 77.733% |
| Formycon AG | 3 | 1 | 0 | 0 | €39.70 | €100.00 | 151.889% |
| Arrowhead Pharmaceuticals Inc. | 13 | 2 | 0 | 0 | €20.40 | €49.32 | 141.784% |
| Biogen Inc. | 44 | 1 | 3 | 0 | €190.15 | €294.45 | 54.851% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €31.40 | €50.00 | 59.236% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €2.83 | - | - |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |
| BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.50 | - | - |
| Nymox Pharmaceutical Corp. | 0 | 3 | 0 | 0 | €0.23 | - | - |
| Cyclacel Pharmaceuticals Inc. | 1 | 13 | 0 | 0 | €0.22 | €19.12 | 8591.136% |
| Daiichi Sankyo Co Ltd | 0 | 1 | 0 | 0 | €28.38 | - | - |
| CytoTools AG | 0 | 1 | 0 | 0 | €0.54 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €11.40 | - | - |
| Karyopharm Therapeutics Inc. | 7 | 2 | 1 | 0 | €1.00 | €3.65 | 265.998% |
| QuidelOrtho Corp. | 6 | 2 | 0 | 0 | €37.00 | €75.48 | 104.011% |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.69 | €1.20 | -28.994% |
| Waters Corp. | 0 | 3 | 0 | 0 | €287.30 | €253.83 | -11.652% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €27.98 | €38.00 | 35.789% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.30 | €0.000 | -100.000% |